Memantine Hydrochloride
NDC 69680-163, memantine hydrochloride, capsule, extended release, from Vitruvias Therapeutics, Inc..
- Product NDC
- 69680-163
- Status
- Listed
- Labeler
- Vitruvias Therapeutics, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213985
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69680-163 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEMANTINE HYDROCHLORIDE21 mg/1
Pharmacologic classes
N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69680-163-30 | 69680016330 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-163-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0c7fd6ab-2ce5-4110-b6e6-9103c8da0765NADAC price for package 69680016330
GET /v1/drugs/nadac/69680016330
Use it
Look up 69680-163 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69680-163 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69680-163. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.